This Article Full Text Full Text (PDF) All Versions of this Article: 24/5/885    most recent 01.ATV.0000124924.21961.c3v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S.-J. Articles by Park, Y.-B. Search for Related Content PubMed PubMed Citation Articles by Park, S.-J. Articles by Park, Y.-B. Related Collections Restenosis Smooth muscle proliferation and differentiation

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:885.)
© 2004 American Heart Association, Inc.

Vascular Biology

Thalidomide as a Potent Inhibitor of Neointimal Hyperplasia After Balloon Injury in Rat Carotid Artery

Seung-Jung Park; Hyo-Soo Kim; Han-Mo Yang; Kyung-Woo Park; Seock-Won Youn; Soo-In Jeon; Dae-Hee Kim; Bon-Kwon Koo; In-Ho Chae; Dong-Joo Choi; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park

From the Cardiovascular Laboratory (S.-J.P., H.-S.K., H.-M.Y., K.-W.P., S.-W.Y., S.-I.J., D.-H.K., B.-K.K., I.-H.C., D.-J.C., B.-H.O., M.-M.L., Y.-B.P.), Clinical Research Institute, Seoul National University Hospital; and the Department of Internal Medicine (S.J.P., H.-S.K., H.-M.Y., K.-W.P., D.-H.K., B.-K.K., I.-H.C., D.-J.C., B.-H.O., M.-M.L., Y.-B.P.), Seoul National University College of Medicine, Seoul, Korea.

Correspondence to Dr Hyo-Soo Kim or Dr Myoung-Mook Lee, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu, Seoul 110-744 Korea. E-mail hyosoo{at}snu.ac.kr or mmlee@snu.ac.kr

Objective— Inflammation is one of the main pathogeneses of neointimal hyperplasia after coronary intervention. Thalidomide, because of its potent antiinflammatory and immunomodulatory properties, is being re-evaluated in several clinical fields. Therefore, we examined whether thalidomide therapy affects neointimal formation.

Methods and Results— In male Sprague-Dawley rats, 100 mg/kg of either thalidomide or sucrose (control) was administered daily from 3 days before injury to 2 weeks after conventional carotid artery denudation injury. Thalidomide administration resulted in a significant reduction of neointimal formation (neointima to media ratio 1.26±0.29 versus 0.35±0.13, P<0.001) and proliferative activity of vascular smooth muscle cells. In addition, arterial macrophage infiltration and local expressions of tumor necrosis factor alpha (TNF-) and basic fibroblast growth factor (bFGF) in the injured arteries as measured by immunohistochemistry and immunoblot analysis were significantly reduced by thalidomide treatment. Serum TNF-, measured by ELISA, was also significantly reduced in the thalidomide-treated animals compared with controls after injury (856±213 versus 449±68 pg/mL on day 3, P=0.001; 129±34 versus 63±18 pg/mL on day 14, P=0.001), and we observed a good positive correlation between the serum TNF- levels and the severity of neointimal growth.

Conclusions— We found that thalidomide, through its antiinflammatory and antiproliferative effects, significantly inhibits neointimal hyperplasia in balloon-injured rat carotid arteries. Our results suggest a potential role of thalidomide as a potent inhibitor of neointimal formation after angioplasty.

Key Words: neointima • inflammation • thalidomide • TNF- • bFGF

This article has been cited by other articles:

				B. Liu, M. Han, and J.-K. Wen Acetylbritannilactone Inhibits Neointimal Hyperplasia after Balloon Injury of Rat Artery by Suppressing Nuclear Factor-{kappa}B Activation J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 292 - 298. [Abstract] [Full Text] [PDF]

				K. Nakamura, S.-i. Yamagishi, T. Matsui, T. Yoshida, K. Takenaka, Y. Jinnouchi, Y. Yoshida, S.-i. Ueda, H. Adachi, and T. Imaizumi Pigment Epithelium-Derived Factor Inhibits Neointimal Hyperplasia after Vascular Injury by Blocking NADPH Oxidase-Mediated Reactive Oxygen Species Generation Am. J. Pathol., June 1, 2007; 170(6): 2159 - 2170. [Abstract] [Full Text] [PDF]

				A. Yndestad, L. E. Vinge, R. Bjornerheim, T. Ueland, J. E. Wang, S. S. Froland, H. Attramadal, P. Aukrust, and E. Oie Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats Eur J Heart Fail, December 1, 2006; 8(8): 790 - 796. [Abstract] [Full Text] [PDF]

				P. S. Monraats, N. M. M. Pires, A. Schepers, W. R. P. Agema, L. S. M. Boesten, M. R. de Vries, A. H. Zwinderman, M. P. M. de Maat, P. A. F. M. Doevendans, R. J. de Winter, et al. Tumor necrosis factor-{alpha} plays an important role in restenosis development FASEB J, December 1, 2005; 19(14): 1998 - 2004. [Abstract] [Full Text] [PDF]